Your session is about to expire
← Back to Search
Intravenous Golimumab for Juvenile Arthritis (GO-VIVA Trial)
GO-VIVA Trial Summary
This trial will study how golimumab enters and leaves the blood and tissues over time in children with arthritis that has not responded to methotrexate.
GO-VIVA Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowGO-VIVA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2016 Phase 4 trial • 205 Patients • NCT02092285GO-VIVA Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Frequently Asked Questions
Is this the first time that Golimumab has been studied in a clinical trial?
"There are currently 243 trials investigating golimumab. Of these, 72 are in phase 3. New york, New York is home to many of these studies, but there are 8089 total locations running trials for this medication."
Which patients does Golimumab help the most?
"While small cell lung cancer is the primary indication for golimumab, this medication can also help patients with other conditions like active pauciarticular juvenile rheumatoid arthritis, head and neck carcinoma, and multiple sclerosis."
Are researchers still looking for people to participate in this trial?
"According to the latest update on clinicaltrials.gov, this trial is not recruiting patients at the moment. The trial was first posted on December 17th, 2014 and was last updated on November 3rd, 2020. Despite this, there are 625 other trials that are actively recruiting patients."
When did the FDA give its okay to Golimumab?
"Golimumab has received a safety score of 3 from our team at Power. This is because Phase 3 trials have shown some efficacy and multiple rounds of data support safety."
Does this experiment have any age restrictions?
"Participants in this trial must have turned 2 years old but cannot be older than 17 years old."
Would I be a good candidate to participate in this research project?
"This clinical study is investigating a new treatment for arthritis in children aged 2-17. To participate, 130 young patients must meet the criteria of having juvenile arthritis."
How many different staff members are managing this clinical trial in different locations?
"Currently, this study is enrolling patients from 16 different locations, which are situated in Philadelphia, Hackensack, Cleveland and other cities. To reduce the demand for travel, it is best to select the clinical trial site that is nearest to you."
For how many people is this research opportunity open?
"This study is no longer recruiting patients. The clinical trial was first posted on December 17th, 2014 and was most recently edited on November 3rd, 2022. However, there are presently 382 studies actively recruiting participants with arthritis and 243 trials for Golimumab that are admitting patients."
Share this study with friends
Copy Link
Messenger